OpGen Raises Total of $20M in Series B Round

The funds raised include part of a $17 million Series B round announced in September and an additional $3 million disclosed now.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories